NZ764838A - Antimicrobial peptides and methods of using same - Google Patents

Antimicrobial peptides and methods of using same

Info

Publication number
NZ764838A
NZ764838A NZ764838A NZ76483818A NZ764838A NZ 764838 A NZ764838 A NZ 764838A NZ 764838 A NZ764838 A NZ 764838A NZ 76483818 A NZ76483818 A NZ 76483818A NZ 764838 A NZ764838 A NZ 764838A
Authority
NZ
New Zealand
Prior art keywords
methods
antimicrobial peptides
same
peptides
antimicrobial
Prior art date
Application number
NZ764838A
Other languages
English (en)
Inventor
Derek James Sheehan
Michael Kuhn
Richard Ewin
Eric Baima
Christopher Zook
Hilary Phelps
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of NZ764838A publication Critical patent/NZ764838A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
    • A01N37/46—N-acyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8281—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for bacterial resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Insects & Arthropods (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
NZ764838A 2017-12-07 2018-12-05 Antimicrobial peptides and methods of using same NZ764838A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762595725P 2017-12-07 2017-12-07
PCT/US2018/064029 WO2019113181A1 (en) 2017-12-07 2018-12-05 Antimicrobial peptides and methods of using same

Publications (1)

Publication Number Publication Date
NZ764838A true NZ764838A (en) 2023-07-28

Family

ID=65003464

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ764838A NZ764838A (en) 2017-12-07 2018-12-05 Antimicrobial peptides and methods of using same

Country Status (27)

Country Link
US (3) US11352396B2 (https=)
EP (2) EP4656726A3 (https=)
JP (1) JP7381465B2 (https=)
KR (3) KR102555177B1 (https=)
CN (1) CN111479824A (https=)
AR (1) AR113618A1 (https=)
AU (3) AU2018378035B2 (https=)
BR (1) BR112020009973A2 (https=)
CA (1) CA3082491A1 (https=)
CL (1) CL2020001464A1 (https=)
CO (1) CO2020006907A2 (https=)
DK (1) DK3720875T3 (https=)
ES (1) ES3041688T3 (https=)
FI (1) FI3720875T3 (https=)
HU (1) HUE072916T2 (https=)
IL (2) IL275074B2 (https=)
LT (1) LT3720875T (https=)
MX (1) MX2020005920A (https=)
NZ (1) NZ764838A (https=)
PH (1) PH12020550942A1 (https=)
PL (1) PL3720875T3 (https=)
PT (1) PT3720875T (https=)
SG (1) SG11202004661QA (https=)
SI (1) SI3720875T1 (https=)
TW (2) TWI786887B (https=)
WO (1) WO2019113181A1 (https=)
ZA (1) ZA202003387B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220307048A1 (en) * 2021-03-23 2022-09-29 Genvor Inc. Antimicrobial peptides
CN113185576B (zh) * 2021-04-09 2023-05-30 倪京满 一类具有RRRF转角的β-发卡型低毒广谱抗菌肽及其应用
US20250042946A1 (en) 2021-12-08 2025-02-06 Oakgrove Bio Llc Biological Production of Histidine-Rich Peptides
EP4198045A1 (en) * 2021-12-16 2023-06-21 Université de Lille Antimicrobial peptides, variants and chemical analogues thereof and their uses
WO2024003890A1 (en) * 2022-06-29 2024-01-04 Omnix Medical Ltd. Novel peptide for treating an infectious disease or condition
CN120309697B (zh) * 2025-06-13 2025-09-02 四川大学 一种用于抗革兰氏阴性菌的多肽药物及应用
CN121378418B (zh) * 2025-12-26 2026-04-03 四川大学 一组针对革兰氏阴性菌的抗菌多肽

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1323166C (zh) * 2003-09-18 2007-06-27 中国农业科学院饲料研究所 一种鲎素的基因及表达其的方法
CN101307316B (zh) * 2008-07-22 2011-03-16 北京中农颖泰生物技术有限公司 抗菌肽cad在枯草杆菌中的分泌表达及重组枯草杆菌表达系统
CN101698682B (zh) * 2009-10-26 2012-05-23 陕西省微生物研究所 一种基于抗菌肽的双功能融合蛋白及其制备方法和用途
CN101817883B (zh) * 2010-03-12 2012-06-13 广东药学院 一种家蝇天蚕素-人溶菌酶融合蛋白及其制备方法和应用
CN101851620B (zh) * 2010-04-21 2012-05-23 吉林农业大学 利用食药用菌生产FGFs的方法
CA2890357C (en) * 2011-07-13 2024-01-09 Solarvest BioEnergy Inc. Methods and uses of a modified cecropin for treating endoparasitic and bacterial infections
CN104177502B (zh) * 2014-08-21 2018-04-24 天津兰瑞生物技术有限公司 一种鲎素肽-抗体融合蛋白及制备方法
CN104988170B (zh) * 2015-08-01 2018-01-16 吉林农业大学 一种融合抗菌肽及其制备方法和应用

Also Published As

Publication number Publication date
TWI746908B (zh) 2021-11-21
PH12020550942A1 (en) 2021-05-10
US20200385429A1 (en) 2020-12-10
ES3041688T3 (en) 2025-11-13
US20250074947A1 (en) 2025-03-06
EP3720875A1 (en) 2020-10-14
BR112020009973A2 (pt) 2020-11-03
CL2020001464A1 (es) 2020-11-06
PT3720875T (pt) 2025-09-18
SI3720875T1 (sl) 2025-11-28
TW202116348A (zh) 2021-05-01
KR20240151857A (ko) 2024-10-18
CO2020006907A2 (es) 2020-06-19
EP4656726A2 (en) 2025-12-03
AU2023229465B2 (en) 2024-06-13
TW201924712A (zh) 2019-07-01
FI3720875T3 (fi) 2025-09-12
HUE072916T2 (hu) 2025-12-28
US11352396B2 (en) 2022-06-07
JP2021505624A (ja) 2021-02-18
CN111479824A (zh) 2020-07-31
AU2018378035B2 (en) 2023-06-15
IL275074A (en) 2020-07-30
KR102555177B1 (ko) 2023-07-12
TWI786887B (zh) 2022-12-11
TW202204376A (zh) 2022-02-01
ZA202003387B (en) 2023-01-25
CA3082491A1 (en) 2019-06-13
AU2024219645A1 (en) 2024-10-03
PL3720875T3 (pl) 2025-10-20
AR113618A1 (es) 2020-05-20
EP3720875B1 (en) 2025-07-16
RU2020118460A (ru) 2022-01-10
IL312730A (en) 2024-07-01
AU2023229465A1 (en) 2023-09-28
JP7381465B2 (ja) 2023-11-15
RU2020118460A3 (https=) 2022-01-10
KR20230110822A (ko) 2023-07-25
KR102713813B1 (ko) 2024-10-11
IL275074B1 (en) 2024-06-01
US20230077604A1 (en) 2023-03-16
LT3720875T (lt) 2025-08-25
AU2018378035A1 (en) 2020-05-28
SG11202004661QA (en) 2020-06-29
WO2019113181A1 (en) 2019-06-13
MX2020005920A (es) 2020-08-20
DK3720875T3 (da) 2025-09-01
US12054518B2 (en) 2024-08-06
KR20200074212A (ko) 2020-06-24
IL275074B2 (en) 2024-10-01
EP4656726A3 (en) 2025-12-31

Similar Documents

Publication Publication Date Title
NZ764838A (en) Antimicrobial peptides and methods of using same
GB201016733D0 (en) Compounds and their use
FI3186395T4 (fi) Kantasolujen siirto kantasoluihin kohdistuvan aineen ja immunoregulatorisen signaloinnin modulaation yhdistelmällä
MY192481A (en) Factor viii chimeric proteins and uses thereof
MX2017004488A (es) Composiciones farmaceuticas que comprenden variantes peptidicos y metodos para su uso.
WO2017125585A3 (en) Novel polypeptides and medical uses thereof
WO2015048333A3 (en) Nutritive polypeptides and formulations thereof, and methods of production and use thereof
WO2017151971A3 (en) METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
MX340446B (es) Metodos para tratar y prevenir infecciones por estafilococo dorado y condiciones asociadas.
HK1256909A1 (zh) Glp-1和其在用於治疗代谢疾病的组合物中的用途
EA201890914A1 (ru) Доставка белка бактериями
WO2020047467A3 (en) Cardiac cell reprogramming with myocardin and ascl1
WO2010141760A3 (en) Antimicrobial peptides
MX2021003773A (es) Composiciones farmacéuticas y métodos relacionados con los agentes terapéuticos óticos.
NZ742241A (en) Daptomycin formulations and uses thereof
MX2018010196A (es) Proteinas de fusion de enzimas lisosomales terapeuticas dirigidas, formulaciones asociadas y usos de las mismas.
WO2015185758A3 (en) Preparation comprising factor viii and von willebrand factor peptides
MX2020006191A (es) Bacteriocinas terapeuticas.
MX2018005411A (es) Polipeptidos anti il-23.
WO2013040478A3 (en) Hyr1-derived compositions and methods of treatment using same
JP2013539776A5 (https=)
MX2017016227A (es) Peptidos anti-infecciosos de amplio espectro.
MY199203A (en) An antibacterial composition and a method of treating staphylococcal infections with the antibacterial composition
WO2015106224A3 (en) Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof
GB2568440A (en) Modified factor H binding protein

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 DEC 2024 BY THOMSON REUTERS

Effective date: 20231101

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 DEC 2025 BY THOMSON REUTERS

Effective date: 20241102

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 DEC 2026 BY THOMSON REUTERS

Effective date: 20251103